The purpose of this research study is to assess the response rate of perifosine in patients with relapsed or refractory Waldenstrom's macroglobulinemia. Perifosine is a newly discovered compound that kills Waldenstrom cells in laboratory experiments. Perifosine has been used in research for the treatment of other types of cancer such as multiple myeloma.